1. Home
  2. NKTX vs GOCO Comparison

NKTX vs GOCO Comparison

Compare NKTX & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • GOCO
  • Stock Information
  • Founded
  • NKTX 2015
  • GOCO 2001
  • Country
  • NKTX United States
  • GOCO United States
  • Employees
  • NKTX N/A
  • GOCO N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • GOCO Specialty Insurers
  • Sector
  • NKTX Health Care
  • GOCO Finance
  • Exchange
  • NKTX Nasdaq
  • GOCO Nasdaq
  • Market Cap
  • NKTX 170.8M
  • GOCO 171.3M
  • IPO Year
  • NKTX 2020
  • GOCO 2020
  • Fundamental
  • Price
  • NKTX $2.05
  • GOCO $17.94
  • Analyst Decision
  • NKTX Strong Buy
  • GOCO Hold
  • Analyst Count
  • NKTX 5
  • GOCO 1
  • Target Price
  • NKTX $15.20
  • GOCO $13.00
  • AVG Volume (30 Days)
  • NKTX 853.6K
  • GOCO 46.7K
  • Earning Date
  • NKTX 03-20-2025
  • GOCO 02-27-2025
  • Dividend Yield
  • NKTX N/A
  • GOCO N/A
  • EPS Growth
  • NKTX N/A
  • GOCO N/A
  • EPS
  • NKTX N/A
  • GOCO N/A
  • Revenue
  • NKTX N/A
  • GOCO $686,459,000.00
  • Revenue This Year
  • NKTX N/A
  • GOCO $1.96
  • Revenue Next Year
  • NKTX N/A
  • GOCO $7.09
  • P/E Ratio
  • NKTX N/A
  • GOCO N/A
  • Revenue Growth
  • NKTX N/A
  • GOCO 30.17
  • 52 Week Low
  • NKTX $1.96
  • GOCO $7.27
  • 52 Week High
  • NKTX $16.24
  • GOCO $20.00
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 39.74
  • GOCO 58.72
  • Support Level
  • NKTX $1.96
  • GOCO $17.00
  • Resistance Level
  • NKTX $2.35
  • GOCO $18.49
  • Average True Range (ATR)
  • NKTX 0.15
  • GOCO 1.18
  • MACD
  • NKTX -0.00
  • GOCO 0.01
  • Stochastic Oscillator
  • NKTX 19.15
  • GOCO 61.28

About NKTX Nkarta Inc.

Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.

About GOCO GoHealth Inc.

GoHealth Inc is a health insurance marketplace in America. Its technology platform leverages modern machine-learning algorithms and helps individuals find the best health insurance plan for their specific needs. The company operates in single operating segment.

Share on Social Networks: